Monday, May 17, 2021
Home Medical Cannabis News Cannabis & CBD Investment News

Cannabis & CBD Investment News

Medical Cannabis Network brings you the latest medical cannabis & CBD investment news from across the global medicinal cannabis & CBD sector.

Professor Mike Barnes outlines opportunity in the UK’s CBD market

Professor Mike Barnes outlines opportunity in the UK’s CBD market

The UK's CBD market has flourished despite the impact of COVID-19. The rest of the world has steamed ahead with the legalisation of medical and...
Currency UK: CBD, currency, and COVID-19

Currency UK: assessing the impact of COVID-19 on the CBD sector

Currency UK Head of Sales Ben Kohler assesses the impact of COVID-19 on foreign exchange within the CBD sector. With CBD still being a relatively...
Cannabidiol market to be worth more than $89bn by 2026

Cannabidiol market to be worth more than $89bn by 2026

A report published by Global Market Insights, Inc., shows that the cannabidiol market size is expected to surpass $89.0bn in revenue by 2026. The report...
What happened to cannabis stocks?

What happened to cannabis stocks?

MCN examines the factors affecting the falling value of cannabis stocks and investigates whether investing in the industry is worth the risk in 2020. Investors...
The bright future of the CBD market and the impact of COVID-19

The bright future of the CBD market and the impact of COVID-19

SovereignPort CEO Sarah Roberts Yetman speaks to MCN about the future of the global CBD market and fears over the long term impact of COVID-19. Sarah...
Exploring growth in the European medical cannabis market

Exploring growth in the European medical cannabis market

Luc Springinsfeld of leading investment bank Bryan, Garnier & Co explores the European medical cannabis market and the rise of medical cannabis investment in...
Malta COVID-19 response secures cannabis industry growth

Malta’s COVID-19 response secures cannabis industry growth

Malta Enterprise has played a pivotal role in ensuring support for research and industry in the face of the COVID-19 epidemic. It says Malta's...
Increased European cannabis demand amidst COVID-19 pandemic

Increased European cannabis demand amidst COVID-19 pandemic

MCN’s partner New Frontier Data explores the effect of COVID-19 European cannabis demand, including consumer trends and the economic future. Despite inevitable regulatory delays due...
What do you know about investing in the cannabis industry?

What do you know about investing in the cannabis industry?

There is a growing number of cannabis companies announcing entry into national & international stock exchanges – here we explore investing in the cannabis...
Benefits and challenges of recruiting in the cannabis industry

Benefits and challenges of recruiting in the cannabis industry

Ever wondered what the recruitment world is like in the cannabis sector? We explore the unique benefits and challenges of recruiting in the burgeoning...
ICBC San Francisco: Alan Brochstein on cannabis investment

ICBC San Francisco: Alan Brochstein on cannabis investment

420 Investor and New Cannabis Ventures founder Alan Brochstein spoke to MCN about cannabis investment and regulation. At the International Cannabis Business Conference (ICBC) in...
Garnier & Co investing in cannabis: driving the growth of Europe’s industry

Bryan, Garnier & Co investing in cannabis: driving growth in Europe

Medical Cannabis Network speaks to Dominic Wilson at Bryan, Garnier & Co, Europe’s leading investment bank for fast-growth health and technology companies, about the...
Currency UK: helping cannabis businesses with international payments

Currency UK: helping cannabis businesses with international payments

Currency UK specialises in the movement of money internationally for cannabis businesses, and offers competitive exchange rates with zero fees. Currency UK specialises in the...
Rize ETF: Europe’s most diversified cannabis equity portfolio

Rize ETF: Europe’s most diversified cannabis equity portfolio

Four new companies have been added to Rize ETF’s specialist thematic Exchange Traded Fund (ETF) to create Europe’s most diversified cannabis equity portfolio. Rize ETF,...
Rize ETF: separating the medical cannabis science from the hype

Rize ETF: separating the medical cannabis science from the hype

Rahul Bhushan, co-founder of European exchange-traded fund issuer Rize ETF, discusses global trends in medical cannabis regulation. The world of cannabis is full of unlikely...
New UK fractional cannabis investment platform launched

New UK fractional cannabis investment platform launched

A new cannabis investment fund app has been launched to provide exposure to businesses focussing on medical cannabis. Wombat Invest, the mobile-only thematic micro-investing app,...
The Cannabis Investor Summit: demonstrating the power of collaboration

The Cannabis Investor Summit: demonstrating the power of collaboration

NNE, collaborating with Invest in Denmark and Invest in Odense, hosted the Cannabis Investor Summit, here MCN shine a light on the strength of...
CBD in Europe report: making the single market real

CBD in Europe report: making the single market real

Pan-European Association, ACTIVE has launched its first English-speaking report: CBD in Europe — Making the Single Market Real. The report is the second ACTIVE report,...
Thematic ETF pioneers launch global medical cannabis ETF

Thematic ETF pioneers launch global medical cannabis ETF

Rize ETF, Europe’s first specialist thematic ETF issuer, has today launched its first two ETFs - including a medical cannabis ETF. The Rize Cybersecurity and...
Cannabinoid treatment specialists Emerald Clinics lists on ASX today

Cannabinoid treatment specialists Emerald Clinics lists on ASX today

Emerald Clinics, lists on the Australian Securities Exchange (ASX) today after raising $6 million in its Initial Public Offering (IPO). Emerald Clinics is a company...

Medical Cannabis eBooks

Medical Cannabis Partners

Pin It on Pinterest